References
- Alobid I, Benítez P, Bernal-Sprekelsen M, Roca J, Mullol J. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 2005;60:452–8.
- Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps group. Rhinol Suppl 2007; 20:1–136.
- Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am 2009;29:657–68.
- Pujols L, Mullol J, Torrego A. Glucocorticoid receptors in human airways. Allergy 2004;59:1042–52.
- Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N Engl J Med 2005;353:1711–23.
- Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 2006;118:128–33.
- Joe SA, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008;139:340–7.
- Hessler JL, Piccirillo JF, Fang D, Vlahiotis A, Banerji A, Levitt RG, Clinical outcomes of chronic rhinosinusitis in response to medical therapy: results of a prospective study. Am J Rhinol 2007;21:10–18.
- Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997;117(3 Pt 2):35–40.
- Nores J-M, Avan P, Bonfils P. Medical management of nasal polyposis: a study in a series of 152 consecutive patients. Rhinology 2003;41:97–102.
- Alobid I, Benitez P, Pujols L, Maldonado M, Bernal-Sprekelsen M, Morello A, Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by longterm intranasal steroid treatment. Rhinology 2006;44:8–13.
- Prehn A, Seger RA, Faber J, Torresani T, Molinari L, Gerber A, The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr Allergy Immunol 1998;9:197–203.
- Casale TB, Dykewicz MS. Clinical implications of the allergic rhinitis-asthma link. Am J Med Sci 2004;327:127–38.
- Demoly P, Rullier-Meyer P, Godard P, Bousquet J, Michel FB. Nasal allergy and asthma: one or two diseases? Bull Acad Natl Med 2005;189:1461–73.
- Peat JK, Salome CM, Woolcock AJ. Factors associated with bronchial hyperresponsiveness in Australian adults and children. Eur Respir J 1992;5:921–9.
- Bonfils P, Avan P. Non-specific bronchial hyperresponsiveness is a risk factor for steroid insensitivity in nasal polyposis. Acta Otolaryngol 2004;124:290–6.
- Bonfils P, Avan P, Malinvaud D. Influence of allergy on the symptoms and treatment of nasal polyposis. Acta Otolaryngol 2006;126:839–44.
- Pujols L, Alobid I, Benítez P, Martínez-Antón A, Roca-Ferrer J. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. Allergy 2008;63:1377–86.
- Hamilos DL, Leung DY, Muro S, Kahn AM, Hamilos SS, Thawley SE, GR beta expression in nasal polyps inflammatory cells and its relationship to the antiinflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001;108:59–68.